Bioceres Crop Solutions C... (BIOX)
| Bid | 3.71 |
| Market Cap | 259M |
| Revenue (ttm) | 407.71M |
| Net Income (ttm) | 2.57M |
| EPS (ttm) | 0.02 |
| PE Ratio (ttm) | 206.5 |
| Forward PE | 15.3 |
| Analyst | Buy |
| Ask | 4.99 |
| Volume | 36,886 |
| Avg. Volume (20D) | 293,055 |
| Open | 4.31 |
| Previous Close | 4.24 |
| Day's Range | 4.11 - 4.24 |
| 52-Week Range | 3.51 - 13.18 |
| Beta | 0.60 |
About BIOX
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides...
Analyst Forecast
According to 4 analyst ratings, the average rating for BIOX stock is "Buy." The 12-month stock price forecast is $10, which is an increase of 142.13% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · seekingalpha.com
Bioceres Is Approaching Distressed Prices, But I Remain On The SidelinesBioceres Crop Solutions Corp. reported a disappointing Q2 2025 with revenues down 24%, driven by Argentina's economic crisis, despite improved international sales. BIOX stock is down 62% year-over-yea...
2 months ago · businesswire.com
Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 ExpectationsROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31...
